These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27543671)

  • 1. Surfactant Protein A Recognizes Outer Membrane Protein OprH on Pseudomonas aeruginosa Isolates From Individuals With Chronic Infection.
    Qadi M; Lopez-Causapé C; Izquierdo-Rabassa S; Mateu Borrás M; Goldberg JB; Oliver A; Albertí S
    J Infect Dis; 2016 Nov; 214(9):1449-1455. PubMed ID: 27543671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A.
    Zhang S; McCormack FX; Levesque RC; O'Toole GA; Lau GW
    PLoS One; 2007 Jun; 2(6):e564. PubMed ID: 17593964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Paulsson M; Singh B; Al-Jubair T; Su YC; Høiby N; Riesbeck K
    J Cyst Fibros; 2015 Sep; 14(5):600-7. PubMed ID: 26047937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response.
    Phuong MS; Hernandez RE; Wolter DJ; Hoffman LR; Sad S
    Cell Death Dis; 2021 Mar; 12(3):241. PubMed ID: 33664232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Interactions of Lipopolysaccharide with an Outer Membrane Protein from Pseudomonas aeruginosa Probed by Solution NMR.
    Kucharska I; Liang B; Ursini N; Tamm LK
    Biochemistry; 2016 Sep; 55(36):5061-72. PubMed ID: 27532487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.
    Davis TJ; Karanjia AV; Bhebhe CN; West SB; Richardson M; Bean HD
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33028687
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A.
    Tan RM; Kuang Z; Hao Y; Lau GW
    J Innate Immun; 2014; 6(2):227-39. PubMed ID: 24080545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A.
    Kuang Z; Hao Y; Walling BE; Jeffries JL; Ohman DE; Lau GW
    PLoS One; 2011; 6(11):e27091. PubMed ID: 22069491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.
    Lamont IL; Konings AF; Reid DW
    Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties.
    Lecaille F; Naudin C; Sage J; Joulin-Giet A; Courty A; Andrault PM; Veldhuizen RA; Possmayer F; Lalmanach G
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1701-9. PubMed ID: 23707200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the interaction of lipopolysaccharide with outer membrane protein H (OprH) from Pseudomonas aeruginosa.
    Edrington TC; Kintz E; Goldberg JB; Tamm LK
    J Biol Chem; 2011 Nov; 286(45):39211-23. PubMed ID: 21865172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response.
    Bauman SJ; Kuehn MJ
    Microbes Infect; 2006 Aug; 8(9-10):2400-8. PubMed ID: 16807039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
    Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
    Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A.
    Tan RM; Kuang Z; Hao Y; Lee F; Lee T; Lee RJ; Lau GW
    Infect Immun; 2015 Apr; 83(4):1339-46. PubMed ID: 25605768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
    Ciofu O; Riis B; Pressler T; Poulsen HE; Høiby N
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2276-82. PubMed ID: 15917521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine stimulation by Pseudomonas aeruginosa--strain variation and modulation by pulmonary surfactant.
    Bufler P; Schikor D; Schmidt B; Griese M
    Exp Lung Res; 2004; 30(3):163-79. PubMed ID: 15195551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.
    Mahenthiralingam E; Campbell ME; Speert DP
    Infect Immun; 1994 Feb; 62(2):596-605. PubMed ID: 8300217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.